Company intelligence / Profile preview

MyBioSource

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

MyBioSource does not develop clinical drugs or clinical candidates. It supplies commercial research reagents; its products have been used in academic and industrial research including peer-reviewed comparative kit studies and assay development, but not in clinical trials

Therapeutic areas: Infectious Diseases
Modalities: Monoclonal antibodyPolyclonal antibodyPeptidesRecombinant proteinELISA kitPCR kit
Industry: Non-Drug Biotech

Partnerships

Bio-Connect (distribution for Benelux)network of manufacturing labs (unnamed)

Beyond the preview

Go deeper on MyBioSource.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyBioSource.

Explore the full profile